MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with P

Propafenone

Propafenone 150mg tablets

Use with caution

Stability notes for Propafenone 150mg tablets

Protect from light and store in airtight containers.

Provenance

This compatibility recommendation is derived from Arythmol 150mg and 300mg tablets (Viatris UK Healthcare Ltd).

Suppliers

Arythmol 150mg tablets (Viatris UK Healthcare Ltd)
Propafenone 150mg tablets (Alliance Healthcare (Distribution) Ltd)

Propafenone 300mg tablets

Use with caution

Stability notes for Propafenone 300mg tablets

Protect from light and store in airtight containers.

Provenance

This compatibility recommendation is derived from Arythmol 150mg and 300mg tablets (Viatris UK Healthcare Ltd).

Supplier

Arythmol 300mg tablets (Viatris UK Healthcare Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.